The Indus Hospital and Health Network formerly Indus Hospitals is a tertiary care multidisciplinary hospital and healthcare system in Pakistan. Construction began in 2004 and it opened in July 2007. It is located in Korangi. It is the first paperless hospital in the country; the hospital has an e-cardiology system.

During the past decade, The Indus Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Indus Hospital" #1 sponsor was "Indus Hospital and Health Network" with 7 trials, followed by "Médecins Sans Frontières, France" with 2 trials sponsored, "Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd." with 1 trials sponsored, "CanSino Biologics Inc." with 1 trials sponsored and "Interactive Research and Development" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Indus Hospital" #1 collaborator was "Epicentre" with 3 trials as a collaborator, "Institute of Tropical Medicine, Belgium" with 3 trials as a collaborator, "Interactive Research and Development" with 3 trials as a collaborator, "Partners in Health" with 3 trials as a collaborator and "Harvard Medical School (HMS and HSDM)" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "The Indus Hospital" are "Tuberculosis" (3 trials), "Pulmonary Tuberculoses" (2 trials), "Tuberculosis, Multidrug-Resistant" (2 trials), "Angioplasty" (1 trials) and "Bacterial Infections" (1 trials). Many other conditions were trialed in "The Indus Hospital" in a lesser frequency.

Most popular intervention types in "The Indus Hospital" are "Other" (7 trials), "Drug" (6 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Bedaquiline" (1 trials), "Bedaquiline 100 MG" (1 trials), "Bupivacaine" (1 trials) and "Clofazimine" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Indus Hospital" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Indus Hospital". 1 are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in The Indus Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Indus Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".